診療グループ

感染症グループ業績

グループ詳細へ戻る

業績

2024年
Original Article
  • Ogo N, Ikegame S, Hotta T, Kan-O K, Yoneshima Y, Shiraishi Y, Tsubouchi K, Tanaka K, Okamoto I

    The Utility and Limitations of Universal Polymerase Chain Reaction Screening for SARS-CoV-2 During Hospital Admission.

    Cureus 16(5): e61470, 2024Pubmed

2023年
Original Article
  • Ikegame S, Carmichael JC, Wells H, Furler O'Brien RL, Acklin JA, Chiu HP, Oguntuyo KY, Cox RM, Patel AR, Kowdle S, Stevens CS, Eckley M, Zhan S, Lim JK, Veit EC, Evans MJ, Hashiguchi T, Durigon E, Schountz T, Epstein JH, Plemper RK, Daszak P, Anthony SJ, Lee B

    Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus.

    Nat Microbiol 8(6): 1108-1122, 2023Pubmed

  • Yamashita S, Ikegame S, Nakatomi K, Sakurai Y, Shuto H, Sato N, Mizoguchi Y, Uehara M, Nakashima N, Okamoto I, Koto H

    Respiratory Virus Infections during the COVID-19 Pandemic Revealed by Multiplex PCR Testing in Japan.

    Microbiol Spectr 11(2): e0416222, 2023Pubmed

グループ詳細へ戻る